Second Course of Accutane Success Rate, Explained

What the label says about a second course

The Accutane label states that a single 15 to 20 week course has produced complete and prolonged remission in many patients [3]. It says a second course should not start until at least 8 weeks after the first is completed, because patients may keep improving while off the drug; the dosing section puts it at 2 months or more off therapy when persistent or recurring severe nodular acne warrants it [3]. The label says the best interval has not been defined for patients who have not finished skeletal growth [3].

Is there a success rate for a second course?

The data below measure how often acne returns after a first course and how many patients go back on the drug.

In one prospective observational study of 180 patients, 116 completed a 12-month follow-up survey: 32.7% had relapsed and 1.72% received a retrial of isotretinoin [2]. Dosing was based on the providers' judgment. Relapse meant receiving a prescription topical or oral acne medication after the course, while retrial meant receiving isotretinoin again. These were different outcomes, so the reported rates should not be treated as equivalent [2]. In that cohort, relapse was 47.4% with a cumulative dose below 220 mg/kg and 26.9% at 220 mg/kg or more (P = .03) [2].

How often does acne return after one course?

In a 2026 single-centre, single-blind trial, patients with moderate-to-severe cystic acne received cumulative doses of 120 or 150 mg/kg [1]. The groups improved comparably in lesion counts and severity grade (all p>0.20) [1]. Twelve months after stopping, relapse was 26.7% at 120 mg/kg and 32.3% at 150 mg/kg (p=0.619) [1].

In a double-blind multicenter study of 150 patients with treatment-resistant nodulocystic acne, split into three equal dose groups, 42% of those given 0.1 mg/kg/day needed retreatment, even though all three doses tested produced a highly significant clinical response [4]. The label states no cumulative mg/kg target; the 120 mg/kg figure comes from the literature, and the 2026 trial calls it the standard dose [3][1].

Do the rules repeat for a second course?

The label says isotretinoin must be dispensed in no more than a 30-day supply, that refills require a new prescription and a new iPLEDGE authorization, and that a Medication Guide is given each time it is dispensed [3]. It also says contraceptive measures must be followed for any subsequent course of therapy [3].